2 Stocks That Could Be Winners in Alzheimer's Disease Along With Biogen
One is Biogen's partner. The other is a potential rival.
Full Article
2 Stocks That Could Be Winners in Alzheimer's Disease Along With Biogen
Motley Fool
0 shares
1 views
You might like
Related news coverage
Why Biogen, Lilly, and Prothena Stocks Soared This Week
The FDA's approval of Biogen's Aduhelm in treating Alzheimer's disease boosted all three stocks.
Motley Fool
Forget Biogen: These 2 Alzheimer's Drug Stocks Could Make You Rich
There are better options for investors looking to profit from potential Alzheimer's disease treatments.
Motley Fool